Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 153 entries
Sorted by: Best Match Show Resources per page
Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine.

Journal of cachexia, sarcopenia and muscle

Ferraro E, Pin F, Gorini S, Pontecorvo L, Ferri A, Mollace V, Costelli P, Rosano G.
PMID: 27239426
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):449-57. doi: 10.1002/jcsm.12097. Epub 2016 Jan 05.

BACKGROUND: The loss of muscle mass (sarcopenia) and the associated reduced muscle strength are key limiting factors for elderly people's quality of life. Improving muscle performance does not necessarily correlate with increasing muscle mass. In fact, particularly in the...

Cite
Ferraro E, Pin F, Gorini S, et al. Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine. J Cachexia Sarcopenia Muscle. 2016;7(4):449-57doi: 10.1002/jcsm.12097.
Ferraro, E., Pin, F., Gorini, S., Pontecorvo, L., Ferri, A., Mollace, V., Costelli, P., & Rosano, G. (2016). Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine. Journal of cachexia, sarcopenia and muscle, 7(4), 449-57. https://doi.org/10.1002/jcsm.12097
Ferraro, Elisabetta, et al. "Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine." Journal of cachexia, sarcopenia and muscle vol. 7,4 (2016): 449-57. doi: https://doi.org/10.1002/jcsm.12097
Ferraro E, Pin F, Gorini S, Pontecorvo L, Ferri A, Mollace V, Costelli P, Rosano G. Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine. J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):449-57. doi: 10.1002/jcsm.12097. Epub 2016 Jan 05. PMID: 27239426; PMCID: PMC4864287.
Copy Download .nbib Format: NLM
Osseous choristoma of the tongue: a review of etiopathogenesis.

Case reports in otolaryngology

Gorini E, Mullace M, Migliorini L, Mevio E.
PMID: 25580337
Case Rep Otolaryngol. 2014;2014:373104. doi: 10.1155/2014/373104. Epub 2014 Dec 14.

Osseous choristoma is a normal bone tissue in an ectopic position. In the oral region lingual localization occurs more frequently and the mass is generally localized on the dorsum of the tongue. Definitive diagnosis is obtained only after histopathologic...

Cite
Gorini E, Mullace M, Migliorini L, et al. Osseous choristoma of the tongue: a review of etiopathogenesis. Case Rep Otolaryngol. 2014;2014:373104doi: 10.1155/2014/373104.
Gorini, E., Mullace, M., Migliorini, L., & Mevio, E. (2014). Osseous choristoma of the tongue: a review of etiopathogenesis. Case reports in otolaryngology, 2014373104. https://doi.org/10.1155/2014/373104
Gorini, Edoardo, et al. "Osseous choristoma of the tongue: a review of etiopathogenesis." Case reports in otolaryngology vol. 2014 (2014): 373104. doi: https://doi.org/10.1155/2014/373104
Gorini E, Mullace M, Migliorini L, Mevio E. Osseous choristoma of the tongue: a review of etiopathogenesis. Case Rep Otolaryngol. 2014;2014:373104. doi: 10.1155/2014/373104. Epub 2014 Dec 14. PMID: 25580337; PMCID: PMC4279709.
Copy Download .nbib Format: NLM
Aggregation of cesium perfluorooctanoate on poly(ethylene glycol) oligomers in water.

The journal of physical chemistry. B

Gianni P, Barghini A, Bernazzani L, Mollica V, Pizzolla P.
PMID: 16671723
J Phys Chem B. 2006 May 11;110(18):9112-21. doi: 10.1021/jp0606614.

The interaction of cesium perfluorooctanoate (CsPFO) with poly(ethylene glycol) (PEG) of different molecular weight (300 < or = MW < or = 20000 Da) has been investigated at 298.15 K by isothermal titration calorimetry (ITC), density, viscosity, and conductivity...

Cite
Gianni P, Barghini A, Bernazzani L, et al. Aggregation of cesium perfluorooctanoate on poly(ethylene glycol) oligomers in water. J Phys Chem B. 2006;110(18):9112-21doi: 10.1021/jp0606614.
Gianni, P., Barghini, A., Bernazzani, L., Mollica, V., & Pizzolla, P. (2006). Aggregation of cesium perfluorooctanoate on poly(ethylene glycol) oligomers in water. The journal of physical chemistry. B, 110(18), 9112-21. https://doi.org/10.1021/jp0606614
Gianni, Paolo, et al. "Aggregation of cesium perfluorooctanoate on poly(ethylene glycol) oligomers in water." The journal of physical chemistry. B vol. 110,18 (2006): 9112-21. doi: https://doi.org/10.1021/jp0606614
Gianni P, Barghini A, Bernazzani L, Mollica V, Pizzolla P. Aggregation of cesium perfluorooctanoate on poly(ethylene glycol) oligomers in water. J Phys Chem B. 2006 May 11;110(18):9112-21. doi: 10.1021/jp0606614. PMID: 16671723.
Copy Download .nbib Format: NLM
Detection of .

Jundishapur journal of microbiology

Samareh-Fekri M, Hashemi Bajgani SM, Shafahi A, Asadi-Zarandi M, Mollaie H, Jamali Paghalhe A.
PMID: 28138371
Jundishapur J Microbiol. 2016 Sep 14;9(11):e32144. doi: 10.5812/jjm.32144. eCollection 2016 Nov.

BACKGROUND: Lung cancer is one of the most common causes of death worldwide. Although smoking and environmental pollutants are the most important risk factors of lung cancer, the role of infectious causes should also be considered in the pathogenesis...

Cite
Samareh-Fekri M, Hashemi Bajgani SM, Shafahi A, et al. Detection of . Jundishapur J Microbiol. 2016;9(11):e32144doi: 10.5812/jjm.32144.
Samareh-Fekri, M., Hashemi Bajgani, S. M., Shafahi, A., Asadi-Zarandi, M., Mollaie, H., & Jamali Paghalhe, A. (2016). Detection of . Jundishapur journal of microbiology, 9(11), e32144. https://doi.org/10.5812/jjm.32144
Samareh-Fekri, Mitra, et al. "Detection of ." Jundishapur journal of microbiology vol. 9,11 (2016): e32144. doi: https://doi.org/10.5812/jjm.32144
Samareh-Fekri M, Hashemi Bajgani SM, Shafahi A, Asadi-Zarandi M, Mollaie H, Jamali Paghalhe A. Detection of . Jundishapur J Microbiol. 2016 Sep 14;9(11):e32144. doi: 10.5812/jjm.32144. eCollection 2016 Nov. PMID: 28138371; PMCID: PMC5240154.
Copy Download .nbib Format: NLM
Single-frequency blue laser fiber amplifier.

Optics letters

Mollaee M, Zhu X, Zong J, Wiersma K, Chavez-Pirson A, Akbulut M, Kaneda Y, LaComb L, Schülzgen A, Peyghambarian N.
PMID: 29400805
Opt Lett. 2018 Feb 01;43(3):423-426. doi: 10.1364/OL.43.000423.

An all-fiber amplifier for a single-frequency blue laser was demonstrated for the first time, to the best of our knowledge. Over 150 mW continuous-wave single-transverse-mode blue laser output was obtained with a 10 m 1000 ppm thulium-doped fluoride fiber...

Cite
Mollaee M, Zhu X, Zong J, et al. Single-frequency blue laser fiber amplifier. Opt Lett. 2018;43(3):423-426doi: 10.1364/OL.43.000423.
Mollaee, M., Zhu, X., Zong, J., Wiersma, K., Chavez-Pirson, A., Akbulut, M., Kaneda, Y., LaComb, L., Schülzgen, A., & Peyghambarian, N. (2018). Single-frequency blue laser fiber amplifier. Optics letters, 43(3), 423-426. https://doi.org/10.1364/OL.43.000423
Mollaee, Masoud, et al. "Single-frequency blue laser fiber amplifier." Optics letters vol. 43,3 (2018): 423-426. doi: https://doi.org/10.1364/OL.43.000423
Mollaee M, Zhu X, Zong J, Wiersma K, Chavez-Pirson A, Akbulut M, Kaneda Y, LaComb L, Schülzgen A, Peyghambarian N. Single-frequency blue laser fiber amplifier. Opt Lett. 2018 Feb 01;43(3):423-426. doi: 10.1364/OL.43.000423. PMID: 29400805.
Copy Download .nbib Format: NLM
Paradoxical effect of fat diet in matrix metalloproteinases induced mitochondrial dysfunction in diabetic cardiomyopathy.

Journal of cardiovascular medicine (Hagerstown, Md.)

Gliozzi M, Scarano F, Musolino V, Carresi C, Scarcella A, Nucera S, Scicchitano M, Ruga S, Bosco F, Maiuolo J, Macrì R, Zito MC, Oppedisano F, Guarnieri L, Mollace R, Palma E, Muscoli C, Mollace V.
PMID: 33633042
J Cardiovasc Med (Hagerstown). 2021 Apr 01;22(4):268-278. doi: 10.2459/JCM.0000000000001046.

AIMS: Diabetic cardiomyopathy represents the main cause of death among diabetic people. Despite this evidence, the molecular mechanisms triggered by impaired glucose and lipid metabolism inducing heart damage remain unclear. The aim of our study was to investigate the...

Cite
Gliozzi M, Scarano F, Musolino V, et al. Paradoxical effect of fat diet in matrix metalloproteinases induced mitochondrial dysfunction in diabetic cardiomyopathy. J Cardiovasc Med (Hagerstown). 2021;22(4):268-278doi: 10.2459/JCM.0000000000001046.
Gliozzi, M., Scarano, F., Musolino, V., Carresi, C., Scarcella, A., Nucera, S., Scicchitano, M., Ruga, S., Bosco, F., Maiuolo, J., Macrì, R., Zito, M. C., Oppedisano, F., Guarnieri, L., Mollace, R., Palma, E., Muscoli, C., & Mollace, V. (2021). Paradoxical effect of fat diet in matrix metalloproteinases induced mitochondrial dysfunction in diabetic cardiomyopathy. Journal of cardiovascular medicine (Hagerstown, Md.), 22(4), 268-278. https://doi.org/10.2459/JCM.0000000000001046
Gliozzi, Micaela, et al. "Paradoxical effect of fat diet in matrix metalloproteinases induced mitochondrial dysfunction in diabetic cardiomyopathy." Journal of cardiovascular medicine (Hagerstown, Md.) vol. 22,4 (2021): 268-278. doi: https://doi.org/10.2459/JCM.0000000000001046
Gliozzi M, Scarano F, Musolino V, Carresi C, Scarcella A, Nucera S, Scicchitano M, Ruga S, Bosco F, Maiuolo J, Macrì R, Zito MC, Oppedisano F, Guarnieri L, Mollace R, Palma E, Muscoli C, Mollace V. Paradoxical effect of fat diet in matrix metalloproteinases induced mitochondrial dysfunction in diabetic cardiomyopathy. J Cardiovasc Med (Hagerstown). 2021 Apr 01;22(4):268-278. doi: 10.2459/JCM.0000000000001046. PMID: 33633042.
Copy Download .nbib Format: NLM
Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data.

Anti-cancer drugs

Ricci AD, Rizzo A, Mollica V, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F.
PMID: 34387596
Anticancer Drugs. 2021 Aug 11; doi: 10.1097/CAD.0000000000001200. Epub 2021 Aug 11.

AIM: We performed a systematic review and meta-analysis to evaluate the role of platinum-based adjuvant chemotherapy (AC) in upper tract urothelial carcinoma.MATERIALS METHODS: Eligible studies were identified using Pubmed/Medline, Cochrane library, Embase and meeting abstracts. Outcomes of interest included:...

Cite
Ricci AD, Rizzo A, Mollica V, et al. Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data. Anticancer Drugs. 2021;doi: 10.1097/CAD.0000000000001200.
Ricci, A. D., Rizzo, A., Mollica, V., Schiavina, R., Fiorentino, M., Brunocilla, E., Ardizzoni, A., & Massari, F. (2021). Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data. Anti-cancer drugs, . https://doi.org/10.1097/CAD.0000000000001200
Ricci, Angela Dalia, et al. "Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data." Anti-cancer drugs vol. (2021). doi: https://doi.org/10.1097/CAD.0000000000001200
Ricci AD, Rizzo A, Mollica V, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F. Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data. Anticancer Drugs. 2021 Aug 11; doi: 10.1097/CAD.0000000000001200. Epub 2021 Aug 11. PMID: 34387596.
Copy Download .nbib Format: NLM
Renal Tumors with Oncocytic and Papillary Features: A Phenotypic and Genotypic Study.

Diagnostics (Basel, Switzerland)

Franceschini T, Giunchi F, Mollica V, Altimari A, Capizzi E, Banfi M, Schiavina R, Fiorentino M, Massari F.
PMID: 33525402
Diagnostics (Basel). 2021 Jan 28;11(2). doi: 10.3390/diagnostics11020184.

The occurrence of kidney oncocytic lesions with an admixed papillary component is not unusual in routine pathology practice. These neoplasms with dual morphology are classically recognized as collision tumors with variable malignant potential. Using immunohistochemistry, we investigated fluorescent in...

Cite
Franceschini T, Giunchi F, Mollica V, et al. Renal Tumors with Oncocytic and Papillary Features: A Phenotypic and Genotypic Study. Diagnostics (Basel). 2021;11(2)doi: 10.3390/diagnostics11020184.
Franceschini, T., Giunchi, F., Mollica, V., Altimari, A., Capizzi, E., Banfi, M., Schiavina, R., Fiorentino, M., & Massari, F. (2021). Renal Tumors with Oncocytic and Papillary Features: A Phenotypic and Genotypic Study. Diagnostics (Basel, Switzerland), 11(2), . https://doi.org/10.3390/diagnostics11020184
Franceschini, Tania, et al. "Renal Tumors with Oncocytic and Papillary Features: A Phenotypic and Genotypic Study." Diagnostics (Basel, Switzerland) vol. 11,2 (2021). doi: https://doi.org/10.3390/diagnostics11020184
Franceschini T, Giunchi F, Mollica V, Altimari A, Capizzi E, Banfi M, Schiavina R, Fiorentino M, Massari F. Renal Tumors with Oncocytic and Papillary Features: A Phenotypic and Genotypic Study. Diagnostics (Basel). 2021 Jan 28;11(2). doi: 10.3390/diagnostics11020184. PMID: 33525402; PMCID: PMC7910958.
Copy Download .nbib Format: NLM
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.

Targeted oncology

Santoni M, Massari F, Grande E, Procopio G, Matrana MR, Rizzo M, De Giorgi U, Basso U, Milella M, Iacovelli R, Aurilio G, Incorvaia L, Buti S, Caffo O, Fornarini G, Carrozza F, Mollica V, Rizzo A, Farag F, Molina-Cerrillo J, Battelli N.
PMID: 34338966
Target Oncol. 2021 Sep;16(5):625-632. doi: 10.1007/s11523-021-00828-z. Epub 2021 Aug 02.

BACKGROUND: Renal cell carcinoma with sarcomatoid differentiation is a highly aggressive form of kidney cancer.OBJECTIVE: We aimed to analyze the outcomes of patients treated with cabozantinib for metastatic renal cell carcinoma with sarcomatoid features.METHODS: We retrospectively collected data from...

Cite
Santoni M, Massari F, Grande E, et al. Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study. Target Oncol. 2021;16(5):625-632doi: 10.1007/s11523-021-00828-z.
Santoni, M., Massari, F., Grande, E., Procopio, G., Matrana, M. R., Rizzo, M., De Giorgi, U., Basso, U., Milella, M., Iacovelli, R., Aurilio, G., Incorvaia, L., Buti, S., Caffo, O., Fornarini, G., Carrozza, F., Mollica, V., Rizzo, A., Farag, F., Molina-Cerrillo, J., & Battelli, N. (2021). Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study. Targeted oncology, 16(5), 625-632. https://doi.org/10.1007/s11523-021-00828-z
Santoni, Matteo, et al. "Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study." Targeted oncology vol. 16,5 (2021): 625-632. doi: https://doi.org/10.1007/s11523-021-00828-z
Santoni M, Massari F, Grande E, Procopio G, Matrana MR, Rizzo M, De Giorgi U, Basso U, Milella M, Iacovelli R, Aurilio G, Incorvaia L, Buti S, Caffo O, Fornarini G, Carrozza F, Mollica V, Rizzo A, Farag F, Molina-Cerrillo J, Battelli N. Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study. Target Oncol. 2021 Sep;16(5):625-632. doi: 10.1007/s11523-021-00828-z. Epub 2021 Aug 02. PMID: 34338966.
Copy Download .nbib Format: NLM
A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents.

Anti-cancer drugs

Rizzo A, Oderda M, Mollica V, Merler S, Morelli F, Fragomeno B, Taveri E, Sorgentoni G, Santoni M, Massari F.
PMID: 34387593
Anticancer Drugs. 2022 Jan 01;33(1):e43-e51. doi: 10.1097/CAD.0000000000001168.

Several novel androgen receptor (AR)-inhibitors have been introduced for nonmetastatic castration-resistant prostate cancer (nmCRPC) treatment, with the improvement of survival outcomes which need to be balanced against the risk of adverse events. We performed a systematic review and meta-analysis...

Cite
Rizzo A, Oderda M, Mollica V, et al. A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents. Anticancer Drugs. 2022;33(1):e43-e51doi: 10.1097/CAD.0000000000001168.
Rizzo, A., Oderda, M., Mollica, V., Merler, S., Morelli, F., Fragomeno, B., Taveri, E., Sorgentoni, G., Santoni, M., & Massari, F. (2022). A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents. Anti-cancer drugs, 33(1), e43-e51. https://doi.org/10.1097/CAD.0000000000001168
Rizzo, Alessandro, et al. "A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents." Anti-cancer drugs vol. 33,1 (2022): e43-e51. doi: https://doi.org/10.1097/CAD.0000000000001168
Rizzo A, Oderda M, Mollica V, Merler S, Morelli F, Fragomeno B, Taveri E, Sorgentoni G, Santoni M, Massari F. A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents. Anticancer Drugs. 2022 Jan 01;33(1):e43-e51. doi: 10.1097/CAD.0000000000001168. PMID: 34387593.
Copy Download .nbib Format: NLM
Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles.

Antioxidants (Basel, Switzerland)

Mollaeva MR, Nikolskaya E, Beganovskaya V, Sokol M, Chirkina M, Obydennyi S, Belykh D, Startseva O, Mollaev MD, Yabbarov N.
PMID: 34943088
Antioxidants (Basel). 2021 Dec 13;10(12). doi: 10.3390/antiox10121985.

Pheophorbide a 17-diethylene glycol ester (XL-8), is a promising high-active derivative of known photosensitizer chlorin e6 used in photodynamic therapy. However, high lipophilicity and poor tumor accumulation limit XL-8 therapeutic application. We developed a novel XL-8 loaded with poly(D,L-lactide-co-glycolide)...

Cite
Mollaeva MR, Nikolskaya E, Beganovskaya V, et al. Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles. Antioxidants (Basel). 2021;10(12)doi: 10.3390/antiox10121985.
Mollaeva, M. R., Nikolskaya, E., Beganovskaya, V., Sokol, M., Chirkina, M., Obydennyi, S., Belykh, D., Startseva, O., Mollaev, M. D., & Yabbarov, N. (2021). Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles. Antioxidants (Basel, Switzerland), 10(12), . https://doi.org/10.3390/antiox10121985
Mollaeva, Mariia R, et al. "Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles." Antioxidants (Basel, Switzerland) vol. 10,12 (2021). doi: https://doi.org/10.3390/antiox10121985
Mollaeva MR, Nikolskaya E, Beganovskaya V, Sokol M, Chirkina M, Obydennyi S, Belykh D, Startseva O, Mollaev MD, Yabbarov N. Oxidative Damage Induced by Phototoxic Pheophorbide a 17-Diethylene Glycol Ester Encapsulated in PLGA Nanoparticles. Antioxidants (Basel). 2021 Dec 13;10(12). doi: 10.3390/antiox10121985. PMID: 34943088.
Copy Download .nbib Format: NLM
TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative review.

Translational andrology and urology

Rizzo A, Mollica V, Cimadamore A, Santoni M, Scarpelli M, Schiavina R, Cheng L, Lopez-Beltran A, Brunocilla E, Montironi R, Massari F.
PMID: 33850788
Transl Androl Urol. 2021 Mar;10(3):1541-1552. doi: 10.21037/tau-20-1109.

The American Joint Committee of Cancer (AJCC) tumor-node-metastasis (TNM) classification, with its periodical updates and modifications, has represented and still represents the basis of cancer staging. The historical, long-standing limitations of anatomic-based TNM staging have been recently "threatened" by...

Cite
Rizzo A, Mollica V, Cimadamore A, et al. TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative review. Transl Androl Urol. 2021;10(3):1541-1552doi: 10.21037/tau-20-1109.
Rizzo, A., Mollica, V., Cimadamore, A., Santoni, M., Scarpelli, M., Schiavina, R., Cheng, L., Lopez-Beltran, A., Brunocilla, E., Montironi, R., & Massari, F. (2021). TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative review. Translational andrology and urology, 10(3), 1541-1552. https://doi.org/10.21037/tau-20-1109
Rizzo, Alessandro, et al. "TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative review." Translational andrology and urology vol. 10,3 (2021): 1541-1552. doi: https://doi.org/10.21037/tau-20-1109
Rizzo A, Mollica V, Cimadamore A, Santoni M, Scarpelli M, Schiavina R, Cheng L, Lopez-Beltran A, Brunocilla E, Montironi R, Massari F. TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative review. Transl Androl Urol. 2021 Mar;10(3):1541-1552. doi: 10.21037/tau-20-1109. PMID: 33850788; PMCID: PMC8039595.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 153 entries